Altmetric

Cancers Related to Immunodeficiencies: Update and Perspectives

File Description SizeFormat 
Cancers Related to Immunodeficiencies: Update and Perspectives.pdfPublished version374.44 kBAdobe PDFView/Open
Title: Cancers Related to Immunodeficiencies: Update and Perspectives
Authors: Mortaz, E
Tabarsi, P
Mansouri, D
Khosravi, A
Garssen, J
Velayati, A
Adcock, IM
Item Type: Journal Article
Abstract: The life span of patients with primary and secondary immunodeficiency is increasing due to recent improvements in therapeutic strategies. While the incidence of primary immunodeficiencies (PIDs) is 1:10,000 births, that of secondary immunodeficiencies are more common and are associated with posttransplantation immune dysfunction, with immunosuppressive medication for human immunodeficiency virus or with human T-cell lymphotropic virus infection. After infection, malignancy is the most prevalent cause of death in both children and adults with (PIDs). PIDs more often associated with cancer include common variable immunodeficiency (CVID), Wiskott-Aldrich syndrome, ataxia-telangiectasia, and severe combined immunodeficiency. This suggests that a protective immune response against both infectious non-self-(pathogens) and malignant self-challenges (cancer) exists. The increased incidence of cancer has been attributed to defective elimination of altered or "transformed" cells and/or defective immunity towards cancer cells. The concept of aberrant immune surveillance occurring in PIDs is supported by evidence in mice and from patients undergoing immunosuppression after transplantation. Here, we discuss the importance of PID defects in the development of malignancies and the current limitations associated with molecular pathogenesis of these diseases and emphasize the need for further knowledge of how specific mutations can modulate the immune system to alter immunosurveillance and thereby play a key role in the etiology of malignancies in PID patients.
Issue Date: 20-Sep-2016
Date of Acceptance: 5-Sep-2016
URI: http://hdl.handle.net/10044/1/41462
DOI: http://dx.doi.org/10.3389/fimmu.2016.00365
ISSN: 1664-3224
Publisher: Frontiers Media
Journal / Book Title: Frontiers in Immunology
Volume: 7
Copyright Statement: © 2016 Mortaz, Tabarsi, Mansouri, Khosravi, Garssen, Velayati and Adcock. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Sponsor/Funder: Wellcome Trust
Funder's Grant Number: 093080/Z/10/Z
Keywords: malignancy
primary immunodeficiency
Publication Status: Published
Article Number: 365
Appears in Collections:National Heart and Lung Institute
Airway Disease
Faculty of Medicine



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Creative Commonsx